高级检索
中华结核和呼吸杂志
期刊首页
过刊列表
高级检索
稿件发表
• 继续医学教育 •
2019年版慢性阻塞性肺疾病全球创议主要更新内容解读（非药物治疗篇）
路明
姚婉贞
作者及单位信息
·
DOI： 10.3760/cma.j.issn.1001-0939.2019.03.023
829
149
0
0
4
0
PDF下载
APP内阅读
摘要

慢性阻塞性肺疾病全球创议（Global initiative for Chronic Obstructive Lung Disease，GOLD）是慢性阻塞性肺疾病（慢阻肺）防治的战略性指导文件。2019年版GOLD报告强调了慢阻肺的异质性，更加重视个体化治疗。本文对慢阻肺非药物治疗方面的相关更新内容进行了解读。

引用本文

路明,姚婉贞. 2019年版慢性阻塞性肺疾病全球创议主要更新内容解读（非药物治疗篇）[J]. 中华结核和呼吸杂志,2019,42(3)：238-240.

DOI:10.3760/cma.j.issn.1001-0939.2019.03.023

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价

版权归中华医学会所有。

未经授权，不得转载、摘编本刊文章，不得使用本刊的版式设计。

除非特别声明，本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

GOLD是慢阻肺防治的战略性指导文件，GOLD 2019 [ 1 ]在2018年的基础上进行了修订更新，新增了66篇文献，纳入了最新的循证医学证据。本文重点介绍慢阻肺非药物治疗方面的更新。
试读结束，您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 report.[EB/OL].[ 2018-12-22]. http://www.goldcopd.org.
返回引文位置
[2]
Tomczyk S , Bennett NM , Stoecker C ,et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)[J]. MMWR Morb Mortal Wkly Rep, 2014,63(37):822-825. DOI: 10.1111/ajt.12073 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Bonten MJ , Huijts SM , Bolkenbaas M ,et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults[J]. N Engl J Med, 2015,372(12):1114-1125. DOI: 10.1056/NEJMoa1408544 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Walters JA , Tang JN , Poole P ,et al. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2017,1:CD001390. DOI: 10.1002/14651858.CD001390.pub4 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Dransfield MT , Harnden S , Burton RL ,et al. Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease[J]. Clin Infect Dis, 2012,55(5):e35-44. DOI: 10.1093/cid/cis513 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Holland AE , Mahal A , Hill CJ ,et al. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial[J]. Thorax, 2017,72(1):57-65. DOI: 10.1136/thoraxjnl-2016-208514 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Bourne S , DeVos R , North M ,et al. Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial[J]. BMJ Open, 2017,7(7):e014580. DOI: 10.1136/bmjopen-2016-014580 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Güell MR , Cejudo P , Ortega F ,et al. Benefits of Long-Term Pulmonary Rehabilitation Maintenance Program in Patients with Severe Chronic Obstructive Pulmonary Disease. Three-Year Follow-up[J]. Am J Respir Crit Care Med, 2017,195(5):622-629. DOI: 10.1164/rccm.201603-0602OC .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Alison JA , McKeough ZJ , Johnston K ,et al. Australian and New Zealand Pulmonary Rehabilitation Guidelines[J]. Respirology, 2017,22(4):800-819. DOI: 10.1111/resp.13025 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Zhang HL , Li JS , Yu XQ ,et al. An evaluation of activity tolerance, patient-reported outcomes and satisfaction with the effectiveness of pulmonary daoyin on patients with chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2017,12:2333-2342. DOI: 10.2147/COPD.S117461 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Zhu S , Shi K , Yan J ,et al. A modified 6-form Tai Chi for patients with COPD[J]. Complement Ther Med, 2018,39:36-42. DOI: 10.1016/j.ctim.2018.05.007 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Fishman A , Martinez F , Naunheim K ,et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema[J]. N Engl J Med, 2003,348(21):2059-2073. DOI: 10.1056/NEJMoa030287 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Strange C , Herth FJ , Kovitz KL ,et al. Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction[J]. BMC Pulm Med, 2007,7(1):10. DOI: 10.1186/1471-2466-7-10 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Kemp SV , Slebos DJ , Kirk A ,et al. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM)[J]. Am J Respir Crit Care Med, 2017,196(12):1535-1543. DOI: 10.1164/rccm.201707-1327OC .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Zoumot Z , Davey C , Jordan S ,et al. Endobronchial valves for patients with heterogeneous emphysema and without interlobar collateral ventilation: open label treatment following the BeLieVeR-HIFi study[J]. Thorax, 2017,72(3):277-279. DOI: 10.1136/thoraxjnl-2016-208865 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Valipour A , Slebos DJ , Herth F ,et al. Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study[J]. Am J Respir Crit Care Med, 2016,194(9):1073-1082. DOI: 10.1164/rccm.201607-1383OC .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Criner GJ , Sue R , Wright S ,et al. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE)[J]. Am J Respir Crit Care Med, 2018,198(9):1151-1164. DOI: 10.1164/rccm.201803-0590OC .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Gompelmann D , Heussel CP , Eberhardt R ,et al. Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema[J]. Respiration, 2012,83(5):400-406. DOI: 10.1159/000336239 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Herth FJ , Ernst A , Baker KM ,et al. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema[J]. Int J Chron Obstruct Pulmon Dis, 2012,7:397-405. DOI: 10.2147/COPD.S31082 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Herth FJ , Valipour A , Shah PL ,et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial[J]. Lancet Respir Med, 2016,4(3):185-193. DOI: 10.1016/S2213-2600(16)00045-X .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Lin SM , Liu KX , Lin ZH ,et al. Does high-flow nasal cannula oxygen improve outcome in acute hypoxemic respiratory failure? A systematic review and meta-analysis[J]. Respir Med, 2017,131:58-64. DOI: 10.1016/j.rmed.2017.08.005 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Frat JP , Coudroy R , Marjanovic N ,et al. High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure[J]. Ann Transl Med, 2017,5(14):297. DOI: 10.21037/atm.2017.06.52 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Nagata K , Kikuchi T , Horie T ,et al. Domiciliary High-Flow Nasal Cannula Oxygen Therapy for Patients with Stable Hypercapnic Chronic Obstructive Pulmonary Disease. A Multicenter Randomized Crossover Trial[J]. Ann Am Thorac Soc, 2018,15(4):432-439. DOI: 10.1513/AnnalsATS.201706-425OC .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
姚婉贞，Email： mocdef.6ab21nehznawoay
B
本文作者均声明不存在利益冲突
评论 （0条）
注册
登录
时间排序
暂无评论，发表第一条评论抢沙发
最新推荐
更多
从慢性阻塞性肺疾病全球创议看指南更新与临床实践
孙永昌
国际呼吸杂志 2024,44(06)
《慢性阻塞性肺疾病全球创议(2024版)》解读：对肺功能的关键描述
黄菲菲 等
国际呼吸杂志 2024,44(06)
2020版慢性阻塞性肺疾病全球创议新引用文献与更新的亮点解读
梁振宇 等
中华结核和呼吸杂志 2020,43(04)
2019年慢性阻塞性肺疾病全球创议更新要点
申永春 等
中华医学杂志 2018,98(48)
MedAI助手（体验版）
文档即答
智问智答
机器翻译
回答内容由人工智能生成，我社无法保证其准确性和完整性，该生成内容不代表我们的态度或观点，仅供参考。
生成快照
文献快照

你好，我可以帮助您更好的了解本文，请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持：

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号
小中大